Organogenesis Holdings Inc. (ORGO) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 656.5M |
| Enterprise Value | 695.67M |
| P/E Ratio | -16.42 |
| PEG Ratio | 0.03 |
| Price/Sales Ratio | 0.6 |
| Price/Book Ratio | 0.8 |
| Enterprise/Revenue | 0.56 |
| Enterprise/EBITDA | 7.71 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0 |
| Operating Margin | 0.02 |
AD
Management Effectiveness
| Return On Assets | -0 |
| Return On Equity | -0 |
Income Statement
| Revenue | 563.03M |
| Revenue/Share | 4.02 |
| Gross Profit | 425.51M |
| EBITDA | 73.91M |
| Net Income | 37.03M |
| Diluted EPS | 0.15 |
Balance Sheet
| Total Cash | 92.1M |
| Total Cash/Share | 0.72 |
| Total Debt | 70.86M |
| Total Debt/Equity | 0.19 |
| Current Ratio | 3.53 |
| Book Value Per Share | 2.98 |
Price History
| 52-Week Change | -46.55 |
| 52-Week High | 7.08 |
| 52-Week Low | 2.04 |
| Moving Average 50 Days | 2.46 |
| Moving Average 200 Days | 3.58 |
Statistics
| Average Volume | 1.13M |
| Shares Outstanding | 128.67M |
| % Held by Institutions | 48.99 |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |
AD
